Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats.
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis.
Neuronal autoantibodies in patients with Rasmussen's encephalitis.
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: No.
MAG, myelin and overcoming growth inhibition in the CNS.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
Lymphopenia in treatment-naive relapsing multiple sclerosis.
Correction of Footdrop Due to Multiple Sclerosis Using the STIMuSTEP Implanted Dropped Foot Stimulator.
Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Benemid: Discount Western Union Generic
[Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.
JC Virus Infects Neurons and Glial Cells in the Hippocampus.
Interim Report Released on Real-World Safety of Fingolimod for Relapsing MS
Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia.
Disease onset in familial and sporadic multiple sclerosis in Argentina.
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.
Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts).
Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies.
The monoamine oxidase inhibitory activity of essential oils obtained from Eryngium species and their chemical composition.

Pages